Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling gsk'

Search results for: 'research area pi3k akt signaling gsk'

Items 1-10 of 64

Page
per page
  1. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     2 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive
      ≥23.27 mg/mL
  2. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  3. SB 216763
    A8240 SB 216763
     3 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor,ATP-competitive,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL
  4. CCT128930 HCl
    A8617 CCT128930 HCl
    Target: Akt
    Summary: AKT inhibitor
      insoluble in H2O; ≥17.1 mg/mL
  5. BKM120
    A3015 BKM120
     1 Citation
    Target: PI3K
    Summary: Inhibitor of pan-Class I PI3K
      ≥20.52 mg/mL
  6. GSK 2837808A
    B4929 GSK 2837808A
    Target: Lactate Dehydrogenases (LDH)
    Summary: Potent, selective lactate dehydrogenase A (LDHA) inhibitor
      ≥9.12 mg/mL
  7. XL147
    A5112 XL147
    Target: PI3K
    Summary: PI3K inhibitor,selective and reversible
      ≥22.45 mg/mL
  8. GSK 4112
    B7460 GSK 4112
    Target: Rev-Erb Receptors
    Summary: Rev-Erbα agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  9. Everolimus (RAD001)
    A8169 Everolimus (RAD001)
     8 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥47.91 mg/mL
  10. TGX-221
    A2681 TGX-221
    Target: PI3K
    Summary: PI3Kβ inhibitor,potent,selective and ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL

Items 1-10 of 64

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 2item
  2. Apoptosis 1 item
  3. Chromatin/Epigenetics 2item
  4. Metabolism 4item
  5. MAPK Signaling 11item
  6. Tyrosine Kinase 3item
  7. DNA Damage/DNA Repair 2item
  8. PI3K/Akt/mTOR Signaling 25item
  9. Cell Cycle/Checkpoint 2item
  10. JAK/STAT Signaling 5item
  11. TGF-β / Smad Signaling 5item
  12. GPCR/G protein 1 item
  13. Stem Cell 7item
  14. Membrane Transporter/Ion Channel 1 item
  15. Endocrinology and Hormones 1 item
  16. Neuroscience 2item
  17. Obesity, Appetite Control & Diabetes 1 item
  18. Other Signal Transduction 1 item
  19. Others 1 item
  20. Immunology/Inflammation 1 item
  21. Cardiovascular 1 item
Reversibility
  1. Irreversible 1 item
Target
  1. Akt 3item
  2. PI3K 13item
  3. Raf 4item
  4. EZH2 1 item
  5. mTOR 7item
  6. Androgen Receptors 1 item
  7. FLT3 1 item
  8. GSK-3 5item
  9. Chk 1 item
  10. VEGFR 2item
  11. PDGFR 2item
  12. Phosphodiesterases (PDEs) 1 item
  13. p38 4item
  14. PKB 1 item
  15. MEK 3item
  16. PORCN 1 item
  17. FGFR 1 item
  18. GABAB Receptors 1 item
  19. STAT 2item
  20. EGFR 1 item
  21. JAK 2item
  22. DNA-PK 2item
  23. HSP90 1 item
  24. Toll-like receptors (TLRs) 1 item
  25. ERK 1 item
  26. PKC 3item
  27. Lactate Dehydrogenases (LDH) 1 item
  28. Free Fatty Acid Receptors 1 item
  29. NO Donors / Precursors 1 item
  30. IL Receptors 1 item
  31. Rev-Erb Receptors 1 item
  32. PKD 1 item
  33. ATM 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 14item
  5. Cancer 37item
  6. Cervical Cancer 1 item
  7. Colon Cancer 6item
  8. Colorectal Cancer 6item
  9. Diabetes 1 item
  10. Glioblastoma 8item
  11. Glioma 4item
  12. Leukemia 5item
  13. Liver Cancer 1 item
  14. Lung Cancer 5item
  15. Lymphoma 2item
  16. Melanoma 4item
  17. Multiple Myeloma 1 item
  18. Myeloma 1 item
  19. Neuroblastoma 1 item
  20. Non-small Cell Lung Cancer 4item
  21. Ovarian Cancer 6item
  22. Pancreatic Cancer 6item
  23. Pancreatic Carcinoma 1 item
  24. Prostate Cancer 7item
  25. Pulmonary Fibrosis 1 item
  26. Renal Cancer 1 item
  27. Rheumatoid Arthritis 2item
  28. Thyroid Cancer 2item
  29. Type 2 Diabetes 1 item